Related references
Note: Only part of the references are listed.Interleukin-17D regulates group 3 innate lymphoid cell function through its receptor CD93
Jinling Huang et al.
IMMUNITY (2021)
Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study
Desiree van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis
Eric Gracey et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans
Petra Bacher et al.
CELL (2019)
The IL-17 Family of Cytokines in Health and Disease
Mandy J. McGeachy et al.
IMMUNITY (2019)
The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17 Cells
Sara Omenetti et al.
IMMUNITY (2019)
Association of synovial tissue polyfunctional T-cells with DAPSA in psoriatic arthritis
Sarah M. Wade et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
The ties that bind: skin, gut and spondyloarthritis
Eric Gracey et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing Treg cells through modification of the intestinal microbiota
Ce Tang et al.
NATURE IMMUNOLOGY (2018)
IL-17 in the immunopathogenesis of spondyloarthritis
Leonie S. Taams et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Progress in our understanding of the pathogenesis of ankylosing spondylitis
Davide Simone et al.
RHEUMATOLOGY (2018)
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
Dominique Baeten et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont
Mo Xu et al.
NATURE (2018)
Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases
Ariane Hammitzsch et al.
SCIENTIFIC REPORTS (2018)
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological diseasemodifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
Desiree van der Heijde et al.
LANCET (2018)
Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis
M. H. Al-Mossawi et al.
NATURE COMMUNICATIONS (2017)
Genome-wide Analysis of STAT3-Mediated Transcription during Early Human Th17 Cell Differentiation
Subhash K. Tripathi et al.
CELL REPORTS (2017)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
An ankylosing spondylitis-associated genetic variant in the IL23R-IL12RB2 intergenic region modulates enhancer activity and is associated with increased Th1-cell differentiation
Amity R. Roberts et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Protein C receptor (PROCR) is a negative regulator of Th17 pathogenicity
Yasuhiro Kishi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression
Gerd Meyer zu Horste et al.
CELL REPORTS (2016)
Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity
Jellert T. Gaublomme et al.
CELL (2015)
CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity
Chao Wang et al.
CELL (2015)
Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
Jacob S. Lee et al.
IMMUNITY (2015)
TH17 cells transdifferentiate into regulatory T cells during resolution of inflammation
Nicola Gagliani et al.
NATURE (2015)
Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation
Francesco Ciccia et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Interleukin 23 in Crohn's Disease
Ahmet Eken et al.
INFLAMMATORY BOWEL DISEASES (2014)
The IL23R A/GIn381 Allele Promotes IL-23 Unresponsiveness in Human Memory T-Helper 17 Cells and Impairs Th17 Responses in Psoriasis Patients
Paola Di Meglio et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci
Adrian Cortes et al.
NATURE GENETICS (2013)
Genomic modulators of the immune response
Julian C. Knight
TRENDS IN GENETICS (2013)
A Validated Regulatory Network for Th17 Cell Specification
Maria Ciofani et al.
CELL (2012)
Microbial-Induced Th17: Superhero or Supervillain?
Mandy J. McGeachy et al.
JOURNAL OF IMMUNOLOGY (2012)
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Christina E. Zielinski et al.
NATURE (2012)
Induction and molecular signature of pathogenic TH17 cells
Youjin Lee et al.
NATURE IMMUNOLOGY (2012)
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
Carl A. Anderson et al.
NATURE GENETICS (2011)
Fate mapping of IL-17-producing T cells in inflammatory responses
Keiji Hirota et al.
NATURE IMMUNOLOGY (2011)
The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF
Mohamed El-Behi et al.
NATURE IMMUNOLOGY (2011)
The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
Paola Di Meglio et al.
PLOS ONE (2011)
Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells
Philip P. Ahern et al.
IMMUNITY (2010)
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Kamran Ghoreschi et al.
NATURE (2010)
Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment
Kiran Nistala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Association of Variants at 1q32 and STAT3 with Ankylosing Spondylitis Suggests Genetic Overlap with Crohn's Disease
Patrick Danoy et al.
PLOS GENETICS (2010)
Frequency and Phenotype of Peripheral Blood Th17 Cells in Ankylosing Spondylitis and Rheumatoid Arthritis
Hui Shen et al.
ARTHRITIS AND RHEUMATISM (2009)
Overexpression of Interleukin-23, but Not Interleukin-17, as an Immunologic Signature of Subdinical Intestinal Inflammation in Ankylosing Spondylitis
Francesco Ciccia et al.
ARTHRITIS AND RHEUMATISM (2009)
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivaylo I. Ivanov et al.
CELL (2009)
Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
Yeonseok Chung et al.
IMMUNITY (2009)
Late Developmental Plasticity in the T Helper 17 Lineage
Yun Kyung Lee et al.
IMMUNITY (2009)
The AP-1 transcription factor Batf controls TH17 differentiation
Barbara U. Schraml et al.
NATURE (2009)
The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo
Mandy J. McGeachy et al.
NATURE IMMUNOLOGY (2009)
A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T-H-17 responses
Elisabetta Volpe et al.
NATURE IMMUNOLOGY (2008)
The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt
Nicolas Manel et al.
NATURE IMMUNOLOGY (2008)
TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology
Mandy J. McGeachy et al.
NATURE IMMUNOLOGY (2007)
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
Melanie Newport et al.
NATURE GENETICS (2007)
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Hania Kebir et al.
NATURE MEDICINE (2007)
The development of inflammatory TH-17 cells requires interferon-regulatory factor 4
Anne Bruestle et al.
NATURE IMMUNOLOGY (2007)
Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells
Eva V. Acosta-Rodriguez et al.
NATURE IMMUNOLOGY (2007)
IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways
Liang Zhou et al.
NATURE IMMUNOLOGY (2007)
STAT3 regulates cytokine-mediated generation of inflammatory helper T cells
Xuexian O. Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
Transforming growth factor-β induces development of the TH17 lineage
PR Mangan et al.
NATURE (2006)
TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells
M Veldhoen et al.
IMMUNITY (2006)
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
LE Harrington et al.
NATURE IMMUNOLOGY (2005)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
DJ Cua et al.
NATURE (2003)
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17
S Aggarwal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
